Exhibit 10.4


Personal Employment Agreement


 


This Personal Employment Agreement (“Agreement”)
is entered into as of August 22, 2014 by and between Foamix Pharmaceuticals Ltd., a company organized under the laws of
the State of Israel, whose principal place of business is located at 2 Chaim Holzman St., Rehovot, Israel, (the “Company”)
and Dr. Dov Tamarkin (“Executive”).


 


		WHEREAS	Executive has been acting as the Chief Executive Officer (“CEO”) of the Company
since 2003; and



 


		WHEREAS	In view of the contemplated listing of the Company’s shares on the NASDAQ Stock Market (“NASDAQ”),
and the anticipated expansion of the Company’s activities and in the Executive’s responsibilities, the Company and the Executive
(collectively: the “Parties” and each: a “Party”) wish to adjust the terms of the Executive’s
employment (as such were set in the Personal Employment Agreement by and between the Company and the Executive on January 2, 2003,
as such was amended from time to time, hereinafter: the “Original Agreement”) terms accordingly, as set forth
herein.



 


NOW THEREFORE, in consideration
of the mutual promises, covenants and other agreements contained herein, and intending to be legally bound, the parties hereto
hereby declare and agree as follows:


 


	1.	Appointment; the Position 	 





 


		1.1.	The Company hereby extends the appointment of Executive and Executive undertakes to continue to
act, as of the Commencement Date (as such term is defined below), as the CEO.



 


		1.2.	In the performance of his tasks and duties and in carrying out his position as the CEO of the Company,
Executive shall report to the Board and shall be subject to the direction and control of the Board.



 


		1.3.	During the Term (as such term is defined below), Executive’s employment shall be on a full time
basis. Executive undertakes to devote his entire business time and attention to the business of the Company and not to undertake
or accept any other paid or unpaid employment or occupation or engage in or be associated with, directly in any other businesses,
duties or pursuits without the prior consent of the Board.



 


		1.4.	Executive shall perform his duties diligently, in good faith and in furtherance of the Company’s
best interests. Executive agrees and undertakes to inform the Company, immediately after Executive becomes aware of it, of any
matter that may in any way raise a conflict of interest between Executive or any member of Executive’s family and the Company.
During the Term, Executive shall not receive any payment, compensation or benefit from any third party in connection, directly
or indirectly, with the execution of Executive’s employment with the Company.



 


		1.5.	Executive shall perform his duties hereunder at the Company’s offices in Israel, in the US and
elsewhere, it being understood and agreed that Executive’s position may involve significant travel abroad.



 



    	 



    	- 2 -



    




	2.
	Executive’s Representations and Warranties 



 


	 	Executive represents and warrants
that the execution and delivery of this Agreement and the fulfillment of Executive’s obligations and performance of the tasks and
duties entrusted to him: (a) will not constitute a default under or conflict with any agreement or undertaking that Executive may
be bound by, including, without limitation to the generality of the aforesaid, any confidentiality or non-competition agreement
towards any previous employer; and (b) do not require the consent of any person or entity.



 


	3.	 Term of Employment 



 


		3.1.	This Agreement shall enter into effect immediately upon, and subject to, the consummation of the
Company’s initial public offering (IPO) on the NASDAQ (the: “Commencement Date”) and Executive’s employment shall
continue until it is terminated as hereafter provided (the term of Executive’s employment shall be referred to herein as the “Term”).
For the avoidance of doubt it is hereby agreed and acknowledged that the execution of this Agreement shall not be deemed as terminating
the Executive’s employment under the Original Agreement, and/or as affecting any of the Executive’s rights which were accumulated
under the Original Agreement up to the Commencement Date.



 


		3.2.	Either party to this Agreement may terminate Executive’s employment hereunder at its own discretion
at any time, by giving a prior written notice of six months to the other Party. Notwithstanding the aforesaid, in case that the
Company’s securities are no longer traded on the NASDAQ and/or on any other stock exchange, the notice period shall be automatically
reduced to three months.



 


		3.3.	Without derogating from the aforesaid the Company shall be entitled to terminate Executive’s employment
with the Company and the employment relationships shall be deemed immediately terminated (as of the notice given by the Company
to that effect) in the event of Cause (as defined hereafter) or in the event of Disability of Executive (as hereinafter defined).
“Cause” shall mean: (a) a material breach of trust including but not limited to any breach of Executive’s obligations
set out in Exhibit B hereto that causes material damage to the Company; or (b) any willful and continued failure to perform
any of Executive’s fundamental functions or duties, which was not cured within 7 days after receipt by Executive of written notice
thereof from the Board. “Disability” shall mean any physical or mental illness or injury as a result of which
Employee remains absent from work for a period of six (6) successive months, or an aggregate of six (6) months in any twelve (12)
month period. Disability shall occur upon the end of such six-month period; Executive’s employment shall be deemed as immediately
terminated in case of his death.



 


		3.4.	During the period following notice of termination by either party, unless
                                                          otherwise determined by the Company in a written notice to Executive, Executive shall continue to perform any and all of his
                                                          duties and shall cooperate with the Company and use his best efforts to assist the transition of his office to the person or
                                                          persons who will assume the his responsibilities.



 



    	 



    	- 3 -



    




		3.5.	For avoidance of doubt, the discontinuance of Executive’s service as a director or chairman of
the Board, for any reason, shall not be deemed as termination of this Agreement or as a breach of this Agreement.



 


	4.	 Proprietary Information; Confidentiality and Non-Competition



 


Executive hereby undertakes
to be bound by the provisions of the Company’s Proprietary Information, Confidentiality and Non-Competition Agreement as
set out in Exhibit B hereto which Executive simultaneously herewith executes.


 


	5.	 Salary



 


		5.1.	Salary. The Company shall pay to Executive for the performance of his undertakings and tasks
and duties entrusted to him, an aggregate monthly salary in the gross amount set forth in Exhibit A hereto (the “Salary”).
Except as specifically set forth in this Agreement, the Salary includes any and all payments to which Executive is or may be entitled
from the Company hereunder and under any applicable law, regulation or agreement. The Salary is to be paid to Executive in accordance
with the Company’s normal and reasonable payroll practices, after deduction of all applicable taxes and like payments.



 


		5.2.	Executive hereby declares and explicitly agrees that his office with the Company is of managerial
level that requires special degree of trust, and therefore the provisions of the Hours of Work and Rest Law 5711-1951 shall not
apply to his employment.



 


		5.3.	Payment of the Salary shall be made no later than the 9th day of each calendar month after the
month for which the Salary is being paid.



 


	6.	 Insurance and Social Benefits



 


		6.1.	The Company and the Executive have decided to apply the terms of the general permit with regard
to employers’ payments to pension funds and to insurance funds, instead of the severance payments, as published in the official
records (“Yalkut Pirsumim”) 4569 of June 30, 1998, which full version is attached to this Argeement as Exhibit
C, and forms an integral part of this Agreement. Therefore, subject to the terms of the Extension Order for Comprehensive
Pension Insurance in the Industry pursuant to the Collective Agreements Law 5717-1957 (the “Extension Order”)
as may be amended from time to time, the Company shall insure Executive as per his choice, either at a pension fund or under an
accepted Manager’s Insurance Scheme(the “Insurance Scheme”). The Company will, on a monthly basis pay to
the Insurance Scheme for the benefit of Executive and shall deduct from Executive’s Salary a respective payment towards such Insurance
Scheme. Unless requested otherwise by Executive, the Insurance Scheme shall be of a managers’ insurance type. The contribution
to the Insurance Scheme will be as follows: (i) the Company will pay an amount equal to 5% (five percent) of the Salary towards
savings, and shall deduct from the Salary an amount equal to 5% (five percent) of the Salary and pay such amount towards savings
on Executive’s behalf; and (ii) the Company will pay an amount equal to 8 1/3% (eight percent and one third of a percent) of the
Salary towards a severance compensation.



 


		6.2.	Under the terms of the Extension Order, to the extent permitted under applicable law, and notwithstanding
any terms of the Insurance Scheme, the Company’s payments for Employees’ Insurance Scheme substitute the statutory
severance pay for all intents and purposes pursuant to Section 14 of the Severance Pay Law (1963) and will be the full and only
compensation to be paid by the Company to Executive in such circumstances in respect of severance pay. In accordance with article
7 to the Extension Order, the Company’s payments for severance pay may not be returned to the Company unless:



 


		6.2.1	Executive’s entitlement for severance pay has been deprived by a judgment, under the provisions
of sections 16 or 17 of the Severance Pay Law (1963), and as long as it was so deprived; or



 


		6.2.2	Executive has withdrawn monies from his pension fund, before he or his heirs were entitled to do
so under the rules of such fund in case of an “Entitling Event”. For the purposes of this Section, “Entitling
Event” shall mean: death, disability or retirement at the age of 60 or more.



 


		6.3	The Company and Executive shall either open and maintain or use an existing (previously used by
Executive) Educational Fund (Keren Hishtalmut; hereinafter: the “Fund”). The terms of the Fund and the amounts
to be paid by the Company and the Executive shall be as set forth in Exhibit A. For the avoidance of doubt, no amount remitted
by the Company to the Fund will be considered as part of the Salary for purposes of any deduction therefrom or calculations of
severance pay or otherwise.



 


		6.4	The Company shall pay an amount of up to 2.5% of the Salary
towards an insurance coverage for the event of loss of working ability (Ovdan Kosher Avoda).



 


		6.5	Executive will bear any and all taxes applicable to an employee in connection
with any amounts paid by Executive and the Company to the Insurance Scheme under this Section 6.



 


		6.6	In the event of termination of Executive’s employment by either Executive
or the Company, other than for Cause, the Company shall transfer to Executive’s possession the Insurance Scheme and the Fund.



 



    	 



    	- 4 -



    

 


	7.	 Additional Benefits



 


		7.1.	The Company shall bear all expenses related to Executive’s use of a cellular phone, in Israel and
abroad.



 


		7.2.	Executive shall be entitled to be reimbursed for Executive’s necessary and actual business out
of pocket expenses in accordance with the Company’s policies, as the same may change from time to time.



 


		7.3.	The Company shall pay the Executive “per diem” payments with regard to Executive’s business
travels abroad (whether by way of a fixed payment per day, or by way of reimbursement for Executive’s out-of-pocket expenses incurred
in connection with such business travels.



 







		7.4.	Subject to the Board’s approval and discretion, Executive shall be entitled to a performance based
bonus payment based on the attainment of certain performance metrics that shall be set by the Board from time to time, and subject
to any approvals that may be required from the Company’s shareholders. Any bonus granted to Executive will not form part
of Executive’s Salary or social benefits and will not be taken into account for the purpose of calculating Executive’s social or
other benefits of any kind.



 


		7.5.	Executive shall be entitled to an annual vacation as set forth in Exhibit A. The Company
shall be entitled to direct use of vacation days at its discretion. Vacation days may be carried forward from one year to the next.



 


		7.6.	Executive’s entitlement to sick leave shall be in accordance with applicable law (but Executive
shall be entitled to 100% payment for sick leave from the first day of his absence).



 


		7.7.	Executive shall be entitled to Recreation Pay (Dmei Havra’a) pursuant to the applicable extension
order.



 


		7.8.	Executive may inform the Company in writing that he wishes to receive the remuneration due to him
under this Agreement by way of payment to a private company controlled by Executive (“Executive’s Entity”), in
which case, within thirty (30) days from receipt of Executive’s notice in this regard:



 


		7.8.1.	The Company, the Executive and the Executive’s Entity shall execute any additional agreements and
undertakings, as shall be reasonably requested by the Company, based on legal advice, in order to ensure that the Company is not
exposed to any financial and/or or other exposure due to such changes in Executive’s terms of service (including, without limitation,
in case that Executive, or any other third party, asserts that notwithstanding the aforesaid changes, the Executive remained an
employee of the Company.



 


		7.8.2.	Subject to Section 7.8.1 above, the Company shall start paying Executive’s Entity all payments
and benefits which were otherwise due to Executive under this Agreement (including, without limitation, all payments due under
Section 6 above, under this Section 7 and under Exhibit B of this Agreement, as well as all payments which were to be made
by the Company to third parties under the said provisions) + VAT as applicable.



 


		7.8.3.	Executive shall confirm in writing that the payment to the Executive’s Entity, as aforesaid, shall
not derogate from Executive’s undertakings and liabilities under this Agreement.



 


	8.	 Miscellaneous



 


		8.1.	The preamble to this Agreement and the exhibits and schedules thereto, constitute an integral part
hereof. Headings are included for reference purposes only and are not to be used in interpreting this Agreement.



 


		8.2.	The laws of the State of Israel shall apply to this Agreement and the sole and exclusive jurisdiction
in any matter arising out of or in connection with this Agreement shall be the Tel-Aviv Regional Labor Court.



 


		8.3.	The provisions of this Agreement are in lieu of the provisions of any collective bargaining agreement,
and therefore, no collective bargaining agreement shall apply with respect to the relationships between the parties hereto (subject
to applicable mandatory provisions of law).



 



    	 



    	- 5 -



    




		8.4.	The Company shall withhold, or charge Executive with all taxes and other compulsory payments as
required under all applicable laws with respect to all payments, benefits and other compensation payable to Executive in connection
with Executive’s employment with Company.



 


		8.5.	The Company shall be entitled to offset from any payments to which Executive shall be entitled
hereunder, any amounts which the Company shall be entitled to receive from Executive at such time.



 


		8.6.	No failure, delay of forbearance of either party in exercising any power or right hereunder shall
in any way restrict or diminish such party’s rights and powers under this Agreement, or operate as a waiver of any breach or nonperformance
by either party of any terms of conditions hereof.



 


		8.7.	In the event it shall be determined under any applicable law that a certain provision set forth
in this Agreement is invalid or unenforceable, such determination shall not affect the remaining provisions of this Agreement unless
the business purpose of this Agreement is substantially frustrated thereby.



 


		8.8.	This Agreement constitutes the entire understanding and agreement between the parties hereto, supersedes
any and all prior discussions, agreements (including without limitation, the Original Agreement, which is hereby substituted by
this Agreement) and correspondence with regard to all subject matters hereof, and may not be amended, modified or supplemented
in any respect, except by a subsequent writing executed by both parties hereto.



 


		8.9.	Executive acknowledges and confirms that all terms of Executive’s employment are personal and confidential,
and undertakes to keep such terms in confidence and refrain from disclosing such terms to any third party.



 


		8.10.	This Agreement serves also as a notification for Employee regarding his terms of employment in
pursuant of the Notification to Employee (terms of Employment) Law, 5762 – 2002.



 


IN WITNESS WHEREOF, the parties
have executed this Agreement as of the date first above written.


 


	
        Foamix Pharmaceuticals Ltd.

         

        /s/ Meir Eini 

        ________________________________________ 

         

        By: Meir Eini
	
        Dov Tamarkin:

         

        /s/ Dov Tamarkin 

        ___________________________________ 

         

        Signature 







    	 



    	- 6 -



    

 


Exhibit A 


 


To Personal Employment Agreement by and
between


 


Foamix Pharmaceuticals Ltd. (the “Company”)
and Dr. Dov Tamarkin (the “Executive”)


 


Executive’s Remuneration


 


	 	 
	ID Number of Executive	00-534452-8
	Executive’s Personal Address	537 Har Hila St. Modiin, M.R 71908, Israel
	Monthly Salary (NIS)	NIS 90,000 (ninety thousand New Israeli Shekels) 
	Bonus	Executive may also be eligible for a gross annual performance bonus of up to 6 months’ Salary, which bonus shall be conditioned upon attainment of individual performance targets and corporate goals to be determined by the Board and the Company’s shareholders, as applicable, and subject also to Executive’s continuous employment with the Company or any of its affiliates in the position of CEO throughout the period to which the respective bonus applies. The Company may decide, from time to time that the Company shall not grant bonuses to the Executive with regard to a specific year. Further – the Company may modify the parameters for the grant of bonus during the respective calendar year, in response to special or unforeseen events. The Board may set targets for a period of more than one year, in which case Executive will be entitled to the bonus (per each year included in such multi-year period) only upon achieving such targets at the end of such period.  If Executives’ employment is terminated by the Company other than for “Cause” prior to the bonus payment date, the bonus shall be prorated to reflect the actual amount of time Executive was employed by the Company during the year for which the bonus was earned.  If Executive’s employment terminates for Cause, Executive shall not be entitled to receive the annual performance bonus or any portion thereof.
	Vacation Days per Year	30 calendar days of annual paid vacation.
	Car	The Company shall reimburse Executive for his expenses related to the purchase, maintenance and use of the car used by Executive in the performance of his duties under this Agreement, in the amount of NIS 10,700 per month. The Company shall also bear all tax expenses related to such reimbursement of expenses, up to an amount of NIS 10,700 per month.
	Keren Hishtalmut	The Company and Executive shall maintain an advanced study fund (Keren Hishtalmut according to law). The Company shall contribute to such Fund an amount equal to 7.5% of the Salary, and Executive shall contribute to such fund an amount equal to 2.5% the Salary. Executive hereby instructs the Company to transfer to such fund the amount of the Executive’s and the Company’s contribution from each monthly Salary payment. The funds in such Fund shall be released to the Executive upon termination of this Agreement. 
	 	 
	 	 	 



 



    	 



    	- 7 -



    




	
        The Company: Foamix Pharmaceuticals Ltd.

         


        /s/ Meir Eini 

        _________________________________ 

        By: Meir Eini

         
	
        Dov Tamarkin:

         


        /s/ Dov Tamarkin 

        ____________________________ 

        Signature 

	 	 
	 	 	 






    	 



    	- 8 -



    

 


Exhibit B


 


to Personal Employment Agreement by and
between Foamix Pharmaceuticals Ltd. (the “Company”) and Dov Tamarkin (the: “Executive”)


 


	Company’s Proprietary Information, Confidentiality


 


and Non-Competition Agreement 



	 	 	 
	 	 	 	 


	1. 	General



 


		1.1.	All the capitalized terms herein shall have the meanings ascribed to them in the Employment Agreement
to which this Exhibit is attached (the “Agreement”); For purposes of any undertaking of the Executive toward
the Company, the term Company shall include all subsidiaries and affiliates of the Company.



 


		1.2.	The Executive’s obligations and representations and the Company’s rights under this Exhibit shall
apply as of the commencement of the employment relationship between the Company and the Executive, regardless of the date of execution
of the Agreement.



 


	2.	 Confidentiality; Proprietary Information



 


		2.1.	Executive acknowledges and agrees that Executive will have access to confidential and proprietary
information (whether originated by the Company or received from third parties) concerning the business and financial activities
of the Company, including information relating to the Company’s research and development, banking, investments, investors, properties,
employees, marketing plans, customers, suppliers, trade secrets, test results, processes, data, know-how, improvements, inventions,
techniques and products (actual or planned). Such information, whether documentary, written, oral or computer generated, shall
be referred to as “Proprietary Information”.



 


		2.2.	Proprietary Information shall be deemed to include any and all proprietary information disclosed
by or on behalf of the Company and irrespective of form but excluding information that the Executive is able to show, through clear
and convincing evidence, (i) was known to Executive prior to Executive’s association with the Company; (ii) is or shall become
part of the public knowledge except as a result of the breach of the Agreement or this Exhibit by the Executive; (iii) reflects
general skills and experience gained during Executive’s engagement by the Company; or (iv) reflects information and data generally
known in the industries or trades in which the Company operates.



 


		2.3.	Executive agrees that all Proprietary Information and all patents, trademarks, copyrights and other
intellectual property and all ownership rights in connection therewith, shall be the sole property of the Company and its assigns.
At all times, both during Executive’s engagement by the Company and after Executive’s termination, Executive will keep in confidence
and trust all Proprietary Information, and the Executive will not use or disclose any Proprietary Information or anything relating
to it without the written consent of the Company, except as may be necessary in the ordinary course of performing Executive’s duties
under the Agreement.



 



    	 



    	- 9 -



    




		2.4.	Upon termination of Executive’s employment with the Company, Executive will promptly deliver to
the Company all documents and materials of any nature pertaining to Executive’s work with the Company, and will not take with Executive
any documents or materials or copies thereof containing any Proprietary Information.



 


		2.5.	At all times, both during Executive’s employment with the Company and thereafter, Executive will
keep in confidence and trust all information in connection with his employment terms with the Company, including, without limitation,
Executive’s salary, social and other benefits, and any other related information (the “Employment Terms”). Executive
will not disclose or discuss any of Executive’s Employment Terms or anything relating to it, except with Executive’s legal counsel,
without the written consent of the Company.



 


		2.6.	Executive’s undertakings set forth in this Section 2 shall remain in full force and effect after
termination of this Agreement or any renewal thereof until the Proprietary Information becomes part of the public domain, if ever,
except as a result of the breach of the Agreement or this Exhibit by the Executive.



 


	3.	 Disclosure and Assignment of Inventions



 


		3.1.	Executive understands that the Company is engaged in a continuous program of research, development,
and production and marketing in connection with its business.



 


		3.2.	From and after the date Executive first became employed with the Company, Executive undertakes
and covenants that Executive will promptly disclose in confidence to the Company all inventions, improvements, designs, concepts,
formulas, techniques, methods, systems, processes, know how, computer software programs, databases, mask works and trade secrets,
whether or not patentable, copyrightable or protectible as trade secrets, that are made or conceived or first reduced to practice
or created by Executive, either alone or jointly with others, during the period of Executive’s employment and in connection with
Executive’s employment (“Inventions”).



 


		3.3.	Executive agrees that all Inventions that (a) are developed using equipment, supplies, facilities
or trade secrets of the Company, (b) result from work performed by Executive for the Company, or (c) relate to the Company’s business
or current or anticipated research and development, will be regarded as Service Invention in the meaning of the Israeli Patent
Law, 5727-1967 and will be the sole and exclusive property of the Company (“Company Inventions”). The conditions
set out in (a), (b) and (c) above are several and not cumulative, and any invention meeting one or more of such conditions shall
be designated a Company Invention.



 


		3.4.	Executive hereby irrevocably transfers and assigns to the Company all worldwide patents, patent
applications, copyrights, mask works, trade secrets and other intellectual property rights in any Company Invention, and any and
all moral rights that Executive may have in or with respect to any Company Invention, and expressly waives any right to any consideration
of any kind with regard to the Company Inventions, the assignment of such and any use thereof, including without limitation any
royalty payment and other payment with respect thereto.



 


		3.5.	Executive agrees to assist the Company, at the Company’s expense, in every reasonable way to obtain
for the Company and enforce patents, copyrights, mask work rights, and other legal protections for the Company’s Inventions in
any and all countries. Executive will execute any documents that the Company may reasonably request for use in obtaining or enforcing
such patents, copyrights, mask work rights, trade secrets and other legal protections. Such obligation shall continue beyond the
termination of Executive’s employment with the Company for a period of 2 years. Executive hereby irrevocably designates and appoints
the Company and its authorized officers and agents as Executive’s agent and attorney in fact, coupled with an interest to act for
and on Executive’s behalf and in Executive’s stead to execute and file any document needed to apply for or prosecute any patent,
copyright, trademark, trade secret, any applications regarding same or any other right or protection relating to any Proprietary
Information (including Company Inventions), and to do all other lawfully permitted acts to further the prosecution and issuance
of patents, copyrights, trademarks, trade secrets or any other right or protection relating to any Proprietary Information (including
Company Inventions), with the same legal force and effect as if executed by the Executive himself.



 



    	 



    	- 10 -



    

 


	4.	  



 


		4.1.	Both Company and Executive acknowledge Executive’s right for freedom of occupation whilst protecting
the Company’s legitimate interests. Therefore Executive agrees and undertakes that, so long as Executive is employed by the Company
and for a period of twelve (12) months thereafter, Executive will not, directly or indirectly, as owner, partner, joint venturer,
stockholder, employee, broker, agent, principal, trustee, corporate officer, director, licensor or in any capacity whatsoever engage
in, become financially interested in, be employed by, or otherwise render services to, any business or venture that is engaged
in any activities involving products, information, processes, technology or equipment that are or could reasonably and imminently
be directly competitive to those of the Company or any of its subsidiaries or affiliates, as conducted as of the date of termination
of Executive’s employment with the Company; provided, however, that Executive may own any securities of any corporation
which is engaged in such business and is publicly owned and traded but in an amount not to exceed at any one time one percent (1%)
of any class of stock or securities of such company, and so long as Executive has no role in the publicly owned and traded company
as director, employee, consultant or otherwise. Executive agrees and understand that his Salary (set forth in Exhibit A) includes
adequate compensation for his undertakings in this Section 4.1 and is at least 20% higher than it would have been should the Executive
had not taken said undertakings.



 


		4.2.	Executive agrees and undertakes that during the period of Executive’s employment and for a period
of twelve (12) months following effective termination, Executive will not, directly or indirectly, including personally or in any
business in which Executive is an officer, director, advisor or shareholder of more than 1% of the equity or voting rights, for
any purpose or in any place, solicit for employment or hire any person employed by the Company (or retained by the Company as a
consultant, if such consultant is prevented thereby from continuing to render its services to the Company) on the date of such
termination or during the preceding twelve (12) months.



 







		4.3.	If any one or more of the terms contained in this Section 4 shall for any reason be held to be
excessively broad with regard to time, geographic scope or activity, the term shall be construed in a manner to enable it to be
enforced to the fullest extent compliant with applicable Israeli law.



 


	 	Date:	Name:	Signature
	 	 	 	 
	 	22/8/2014	Dov Tamarkin	/s/ Dov Tamarkin



 






    	 



    	- 11 -